EGFR and cardiovascular disorder: EGFR transactivation appears as a critical actor in cardiovascular disease pathophysiology [12], and in vivo and in vitro evidence concerning the role of the crosstalk of EGFR with TP and AT1R in these processes has been piling up [13,14,15].